SALEM, N.H.--Gamma Medica, developer of advanced digital molecular imaging technologies for the detection of breast cancer, announced today that it has formed a strategic advisory board comprised of distinguished clinicians and thought leaders with expertise in women’s health technologies and diagnostic imaging. Robert Cascella, former chief executive officer of Hologic, will chair the strategic advisory board. The board will provide strategic and operational counsel as Gamma Medica continues the development and commercialization of its LumaGEM® Molecular Breast Imaging system.

Welcome to the results of the sixth annual radiology-group survey. Recently, I had lunch (at a conference on health care’s future) with the former CEO of a large teleradiology company, and he asked how radiology groups were responding to changes in the marketplace. Over the years, we had discussed that we both felt that radiology groups would get larger and that we would see national radiology groups, in the future. The question was never whether this would happen—but rather, when. I think that the answer is either soon or now.

Welcome to the fifth annual radiology-group survey results. A different approach in gathering information was used this year. In the past, the survey was 100% based on submissions provided by the groups themselves. This year, the Radiology Business Journal staff researched the practice market and sought out large groups, asking them to submit information. Some entries were based on information taken from the groups’ websites. The results look complete and do represent the largest 100 radiology groups owned by radiologists in the country.